-
1
-
-
0029552201
-
Management des frühen vorzeitigen blasensprungs an geburtshilflichen Abteilungen in Deutschland
-
Ragosch V, Hundertmark S, Fuhr N, Hopp H, Weitzel H. Management des frühen vorzeitigen Blasensprungs an geburtshilflichen Abteilungen in Deutschland. Z Geburtsh Neonatol 1995; 199: 236-242
-
(1995)
Z Geburtsh Neonatol
, vol.199
, pp. 236-242
-
-
Ragosch, V.1
Hundertmark, S.2
Fuhr, N.3
Hopp, H.4
Weitzel, H.5
-
2
-
-
0031834647
-
Concomitant use of glucocorticoids: A comparison of two metaanalyses on antibiotic treatment in preterm premature rupture of membranes
-
Leitich H, Egarter C, Reisenberger K, Kaider A, Berghammer P. Concomitant use of glucocorticoids: a comparison of two metaanalyses on antibiotic treatment in preterm premature rupture of membranes. Am J Obstet Gynecol 1998; 178: 899-908
-
(1998)
Am J Obstet Gynecol
, vol.178
, pp. 899-908
-
-
Leitich, H.1
Egarter, C.2
Reisenberger, K.3
Kaider, A.4
Berghammer, P.5
-
3
-
-
0018411515
-
Intrauterine infektionen in der schwangerschaft. Bedeutung des vorzeitigen blasensprungs und früher lungenkomplikationen
-
Beller FK, Dame WR, Muller KM, Nienhaus H. Intrauterine Infektionen in der Schwangerschaft. Bedeutung des vorzeitigen Blasensprungs und früher Lungenkomplikationen. Zentralbl Gynakol 1979; 101: 382-393
-
(1979)
Zentralbl Gynakol
, vol.101
, pp. 382-393
-
-
Beller, F.K.1
Dame, W.R.2
Muller, K.M.3
Nienhaus, H.4
-
4
-
-
0031894269
-
Sepsis und SIRS (Systemic Inflammatory Response Syndrome) im Wochenbett
-
Sauer I, Schröder W, Raumanns J, Rath W. Sepsis und SIRS (Systemic Inflammatory Response Syndrome) im Wochenbett. Z Geburtsh Neonatol 1998; 202: 30-34
-
(1998)
Z Geburtsh Neonatol
, vol.202
, pp. 30-34
-
-
Sauer, I.1
Schröder, W.2
Raumanns, J.3
Rath, W.4
-
5
-
-
23444446083
-
Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis
-
Natanson C, Hoffmann WD, Suffredini A, Eichacker PQ, Danner RL. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 1994; 120: 771-783
-
(1994)
Ann Intern Med
, vol.120
, pp. 771-783
-
-
Natanson, C.1
Hoffmann, W.D.2
Suffredini, A.3
Eichacker, P.Q.4
Danner, R.L.5
-
6
-
-
0027529447
-
The search for a magic bullet to fight sepsis
-
Bone RC. The search for a magic bullet to fight sepsis (editorial). JAMA 1993; 269: 2266-2267
-
(1993)
JAMA
, vol.269
, pp. 2266-2267
-
-
Bone, R.C.1
-
7
-
-
0030660194
-
Procalcitonin - A new indicator of the systemic response to severe infection
-
Karzai W, Oberhoffer M, Meier-Hellmann A, Reinhart K. Procalcitonin - A new indicator of the systemic response to severe infection. Infection 1997; 25: 329-334
-
(1997)
Infection
, vol.25
, pp. 329-334
-
-
Karzai, W.1
Oberhoffer, M.2
Meier-Hellmann, A.3
Reinhart, K.4
-
8
-
-
0031596258
-
Procalcitonin. A new diagnostic parameter for severe infection and sepsis
-
Oberhoffer M, Karzai W, Meier-Hellmann A, Reinhart K. Procalcitonin. A new diagnostic parameter for severe infection and sepsis. Anästhesist 1998; 47: 581-587
-
(1998)
Anästhesist
, vol.47
, pp. 581-587
-
-
Oberhoffer, M.1
Karzai, W.2
Meier-Hellmann, A.3
Reinhart, K.4
-
9
-
-
0029992699
-
Early detection and markers of sepsis
-
Parsons PE, Moss M. Early detection and markers of sepsis. Clin Chest Med 1996; 17: 199-212
-
(1996)
Clin Chest Med
, vol.17
, pp. 199-212
-
-
Parsons, P.E.1
Moss, M.2
-
10
-
-
0031776575
-
Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis
-
Nylen ES, Whang KT, Snider RH, Steinwald PM, White JC, Becker KL. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 1998; 26: 1001-1006
-
(1998)
Crit Care Med
, vol.26
, pp. 1001-1006
-
-
Nylen, E.S.1
Whang, K.T.2
Snider, R.H.3
Steinwald, P.M.4
White, J.C.5
Becker, K.L.6
-
11
-
-
0027466275
-
High serum pro-calcitonin concentrations in patients with sepsis and infection
-
Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum pro-calcitonin concentrations in patients with sepsis and infection. Lancet 1993; 34: 515-518
-
(1993)
Lancet
, vol.34
, pp. 515-518
-
-
Assicot, M.1
Gendrel, D.2
Carsin, H.3
Raymond, J.4
Guilbaud, J.5
Bohuon, C.6
-
12
-
-
0030998194
-
Procalcitonin, a marker of bacterial infection
-
Gendrel D, Bohuon C. Procalcitonin, a marker of bacterial infection. Infection 1997; 25: 133-134
-
(1997)
Infection
, vol.25
, pp. 133-134
-
-
Gendrel, D.1
Bohuon, C.2
-
13
-
-
0030591996
-
Procalcitonin in diagnosis of severe infections
-
Al-Nawas B, Krammer I, Shah PM. Procalcitonin in diagnosis of severe infections. Eur J Med Res 1996; 18: 331-333
-
(1996)
Eur J Med Res
, vol.18
, pp. 331-333
-
-
Al-Nawas, B.1
Krammer, I.2
Shah, P.M.3
-
14
-
-
0031842374
-
Procalcitonin: A new parameter for the diagnosis of bacterial infection in the peri-operative period
-
Oczenski W, Fitzgerald RD, Schwarz S. Procalcitonin: a new parameter for the diagnosis of bacterial infection in the peri-operative period. Eur J Anaesthesiol 1998; 15: 202-209
-
(1998)
Eur J Anaesthesiol
, vol.15
, pp. 202-209
-
-
Oczenski, W.1
Fitzgerald, R.D.2
Schwarz, S.3
-
15
-
-
0030822181
-
Procalcitonin as a marker of bacterial sepsis in patients infected with HIV-1
-
Gerard Y, Hober D, Assicot M, Alfandari S, Ajana F, Bourez JM, Chidiac C, Mouton Y, Bohuon C, Wattre P. Procalcitonin as a marker of bacterial sepsis in patients infected with HIV-1. J Infect 1997; 35: 41-46
-
(1997)
J Infect
, vol.35
, pp. 41-46
-
-
Gerard, Y.1
Hober, D.2
Assicot, M.3
Alfandari, S.4
Ajana, F.5
Bourez, J.M.6
Chidiac, C.7
Mouton, Y.8
Bohuon, C.9
Wattre, P.10
-
16
-
-
0030982476
-
Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody- associated vasculitis) and invasive bacterial infection
-
Eberhard OK, Haubitz M, Brunkhorst FM, Kliem V, Koch KM, Brunkhorst R. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody- associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997; 40: 1250-1256
-
(1997)
Arthritis Rheum
, vol.40
, pp. 1250-1256
-
-
Eberhard, O.K.1
Haubitz, M.2
Brunkhorst, F.M.3
Kliem, V.4
Koch, K.M.5
Brunkhorst, R.6
-
17
-
-
0031746419
-
Procalcitonin - Marker or mediator?
-
Braithwaite SS. Procalcitonin - Marker or mediator? Crit Care Med 1998; 26: 977-978
-
(1998)
Crit Care Med
, vol.26
, pp. 977-978
-
-
Braithwaite, S.S.1
-
18
-
-
4244199050
-
Human peripheral blood mononuclear cells express mRNA for procalcitonin; modulation by lipopolysaccharides and sepsis related cytokines
-
Oberhoffer M, Rußwurm S, Stonans I, Stonane E, Vogelsang H, Junker U, Jäger L, Reinhart K. Human peripheral blood mononuclear cells express mRNA for procalcitonin; modulation by lipopolysaccharides and sepsis related cytokines. Crit Care 1998; 2 suppl. 1: P35
-
(1998)
Crit Care
, vol.2
, Issue.SUPPL. 1
-
-
Oberhoffer, M.1
Rußwurm, S.2
Stonans, I.3
Stonane, E.4
Vogelsang, H.5
Junker, U.6
Jäger, L.7
Reinhart, K.8
|